I agree that this site is using cookies. You can find further informations here.
X
Malik, Raleigh
37  results:
Search for persons X
?
1

SAT664 Obesity And Overweight Diagnosis, Physician Prescrip..:

Ezendu, Kyrian ; Choong, Casey Kar-Chan ; Brown, Madeline..
Journal of the Endocrine Society.  7 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1210/..
 
?
2

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg f..:

le Roux, Carel W. ; Hankosky, Emily R. ; Wang, Duzhe...
Diabetes, Obesity and Metabolism.  25 (2023)  9 - p. 2626-2633 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Physician Perceptions of Dose Escalation for Type 2 Diabete..:

Boye, Kristina S. ; Jordan, Jessica B. ; Malik, Raleigh.
Diabetes Therapy.  15 (2023)  2 - p. 381-393 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Efficacy of Dulaglutide Expanded Doses by Baseline A1C Cate..:

Frias, Juan Pablo ; Bonora, Enzo ; Cox, David A...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A332-A333 , 2021
Link: https://doi.org/10.1210/..
 
?
5

Accelerating Pediatric Cancer Drug Development: Challenges ..:

Khan, Tahira ; Stewart, Mark ; Blackman, Samuel...
Therapeutic Innovation & Regulatory Science.  53 (2019)  2 - p. 270-278 , 2019
Link: https://doi.org/10.1177/..
 
?
6

Tirzepatide in Hispanic/Latino Patients With Type 2 Diabete..:

Frías, Juan Pablo ; Galindo, Rodolfo J ; Wang, Hui...
The Journal of Clinical Endocrinology & Metabolism.  109 (2023)  2 - p. 557-568 , 2023
Link: https://doi.org/10.1210/..
 
?
7

OR28-4 Efficacy and Safety of Tirzepatide Versus Semaglutid..:

Benneyworth, Brian D ; Brown, Katelyn ; Malik, Raleigh E..
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A355-A356 , 2022
Link: https://doi.org/10.1210/..
 
?
8

Greater Adherence and Persistence with Injectable Dulagluti..:

Mody, Reema ; Manjelievskaia, Janna ; Marchlewicz, Elizabeth H....
Clinical Therapeutics.  44 (2022)  4 - p. 537-554 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Patient Perceptions of and Preferences Between Characterist..:

Boye, Kristina S. ; Jordan, Jessica B. ; Malik, Raleigh E...
Diabetes Therapy.  12 (2021)  9 - p. 2387-2403 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Effect of dulaglutide 3.0 and 4.5 mg on weight in patients ..:

Bonora, Enzo ; Frias, Juan P. ; Tinahones, Francisco J....
Diabetes, Obesity and Metabolism.  23 (2021)  10 - p. 2242-2250 , 2021
Link: https://doi.org/10.1111/..
 
?
11

Glycaemic efficacy of an expanded dose range of dulaglutide..:

Frias, Juan P. ; Bonora, Enzo ; Cox, David A....
Diabetes, Obesity and Metabolism.  23 (2021)  12 - p. 2819-2824 , 2021
Link: https://doi.org/10.1111/..
 
?
12

Shared Learnings on the New EMA First-in-Human and Early Cl..:

van der Laan, Jan Willem ; Benson, Charles T. ; Janssens, Walter...
Therapeutic Innovation & Regulatory Science.  54 (2020)  2 - p. 462-467 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Real-World Effectiveness of Dulaglutide in Patients with Ty..:

Robinson, Susan ; Boye, Kristina S. ; Mody, Reema...
Diabetes Therapy.  11 (2020)  7 - p. 1437-1466 , 2020
Link: https://doi.org/10.1007/..
 
?
14

The Relationship Between Timing of Initiation on a Glucagon..:

Boye, Kristina S. ; Mody, Reema ; Lage, Maureen J..
Clinical Therapeutics.  42 (2020)  9 - p. 1812-1817.e2 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Shared Learnings on the New EMA First-in-Human and Early Cl..:

van der Laan, Jan Willem ; Benson, Charles T. ; Janssens, Walter...
Therapeutic Innovation & Regulatory Science.  , 2019
Link: https://doi.org/10.1177/..
 
1-15